RANDOMISED, PLACEBO-CONTROLLED, LONG-TERM STUDY OF RISPERIDONE LONG ACTING INJECTABLE IN RELAPSE PREVENTION IN BIPOLAR DISORDER PATIENTS

被引：0
|
作者：
Quiroz, Jorge [1 ]
Palumbo, Joseph [1 ]
Karcher, Keith [1 ]
Kushner, Stuart [1 ]
Kusumakar, Vivek [1 ]
Yatham, Lakshmi [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
BIPOLAR DISORDERS | 2009年 / 11卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：785 / 785
页数：1
相关论文
共 50 条
  • [41] Subjective attitude to risperidone long-acting injectable (RLAI): Results from a long-term Italian study in subjects with schizophrenia or schizoaffective disorder
    Rossi, A.
    Bernareggi, M. M.
    Giustra, M. G.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S167 - S167
  • [42] Adjunctive long-acting risperidone delays mood episode relapse in patients with frequently relapsing bipolar disorder
    Alphs, L.
    Haskins, J. T.
    Turkoz, I.
    Turner, N.
    Schreiner, A.
    Macfadden, W.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S441 - S442
  • [43] Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial
    Munoz, Gerard
    de Gracia, Javier
    Buxo, Maria
    Alvarez, Antonio
    Vendrell, Montserrat
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (01)
  • [44] Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia
    Kane, J. M.
    Mackle, M.
    Snow-Adami, L.
    Zhao, J.
    Szegedi, A.
    Panagides, J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 223 - 223
  • [45] Double-blind, placebo-controlled trial of asenapine in prevention of relapse after long-term treatment of schizophrenia
    Mackle, M.
    Snow-Adami, L.
    Zhao, J.
    Szegedi, A.
    Panagides, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S543 - S543
  • [46] Relapse prevention of disruptive behavioral disorders in children and adolescents: A long-term trial of risperidone versus placebo
    Reyes, M
    Findling, R
    Buitelaar, J
    Augustyns, I
    Eerdekens, M
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S235 - S235
  • [47] Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study
    De la Gandara, Jesus
    San Molina, Luis
    Rubio, Gabriel
    Rodriguez-Morales, Alexander
    Hidalgo Borrajo, Rebeca
    Antonio Buron, Jose
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (10) : 1463 - 1474
  • [48] Long-term relapse prevention: A stratified dose comparison of risperidone and haloperidol
    Vangeneugden, T
    Augustyns, I
    Curinckx, H
    Ingham, M
    Mahmoud, R
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 175 - 176
  • [49] Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder: A 1-year retrospective cohort study
    Chan, Hsue-Wei
    Huang, Chin-Yu
    Feng, Wen-Jui
    Yen, Yung-Chieh
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2016, 205 : 360 - 364
  • [50] Effects of adding risperidone long-acting injectable to treatment-as-usual in patients with frequently relapsing bipolar disorder
    Frye, Mark A.
    Mahmoud, Ramy
    Turkoz, Ibrahim
    Gharabawi, Georges
    Kujawa, Mary
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S173 - S173
12345